Sickle Cell Disease Drugs Market Size

Sickle Cell Disease Drugs Market size was over USD 2.71 billion in 2023 and is poised to cross USD 18.45 billion by 2036, growing at more than 15.9% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of sickle cell disease drugs is evaluated at USD 3.05 billion.

The growth of the market can be attributed to the growing cases of various sickle cell diseases, such as, sickle cell anemia, and sickle hemoglobin- C, among others. The cause of this disease is the deletion of certain chromosomes in the genes, which causes the red blood cells (RBC) to elongate and get a sickle-like shape. Treatment of the disease majorly aims at curing symptoms, including, pain crisis, swelling in hands and legs, dizziness, and shortage of oxygen. This raises the scope for R&D activities for developing novel drugs and treatment methods for this disease, which is estimated to boost the growth of the market.